Structure

Physi-Chem Properties

Molecular Weight:  482.12
Volume:  459.711
LogP:  1.896
LogD:  2.23
LogS:  -4.919
# Rotatable Bonds:  4
TPSA:  166.14
# H-Bond Aceptor:  10
# H-Bond Donor:  6
# Rings:  5
# Heavy Atoms:  10

MedChem Properties

QED Drug-Likeness Score:  0.325
Synthetic Accessibility Score:  4.199
Fsp3:  0.24
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.291
MDCK Permeability:  5.6396625041088555e-06
Pgp-inhibitor:  0.048
Pgp-substrate:  0.036
Human Intestinal Absorption (HIA):  0.167
20% Bioavailability (F20%):  0.02
30% Bioavailability (F30%):  0.988

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.03
Plasma Protein Binding (PPB):  93.77666473388672%
Volume Distribution (VD):  0.633
Pgp-substrate:  9.719922065734863%

ADMET: Metabolism

CYP1A2-inhibitor:  0.052
CYP1A2-substrate:  0.156
CYP2C19-inhibitor:  0.04
CYP2C19-substrate:  0.06
CYP2C9-inhibitor:  0.576
CYP2C9-substrate:  0.779
CYP2D6-inhibitor:  0.097
CYP2D6-substrate:  0.225
CYP3A4-inhibitor:  0.642
CYP3A4-substrate:  0.256

ADMET: Excretion

Clearance (CL):  7.02
Half-life (T1/2):  0.451

ADMET: Toxicity

hERG Blockers:  0.064
Human Hepatotoxicity (H-HT):  0.303
Drug-inuced Liver Injury (DILI):  0.932
AMES Toxicity:  0.159
Rat Oral Acute Toxicity:  0.494
Maximum Recommended Daily Dose:  0.884
Skin Sensitization:  0.783
Carcinogencity:  0.141
Eye Corrosion:  0.003
Eye Irritation:  0.368
Respiratory Toxicity:  0.044

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC279209

Natural Product ID:  NPC279209
Common Name*:   Silychristin
IUPAC Name:   (2R,3R)-3,5,7-trihydroxy-2-[(2R,3S)-7-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-2,3-dihydro-1-benzofuran-5-yl]-2,3-dihydrochromen-4-one
Synonyms:   (+)-Silychristin; Silychristin
Standard InCHIKey:  BMLIIPOXVWESJG-LMBCONBSSA-N
Standard InCHI:  InChI=1S/C25H22O10/c1-33-18-6-10(2-3-15(18)28)23-14(9-26)13-4-11(5-17(30)25(13)35-23)24-22(32)21(31)20-16(29)7-12(27)8-19(20)34-24/h2-8,14,22-24,26-30,32H,9H2,1H3/t14-,22+,23+,24-/m1/s1
SMILES:  COc1cc(ccc1O)[C@H]1[C@H](CO)c2cc(cc(c2O1)O)[C@@H]1[C@H](C(=O)c2c(cc(cc2O1)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL130493
PubChem CID:   441764
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0003405] 2-arylbenzofuran flavonoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO21361 Anastatica hierochuntica Species Brassicaceae Eukaryota n.a. n.a. n.a. PMID[12643908]
NPO5645 Silybum marianum Species Asteraceae Eukaryota n.a. whole plant n.a. PMID[16394559]
NPO21361 Anastatica hierochuntica Species Brassicaceae Eukaryota n.a. n.a. n.a. PMID[20189399]
NPO5645 Silybum marianum Species Asteraceae Eukaryota n.a. n.a. n.a. PMID[24456525]
NPO5645 Silybum marianum Species Asteraceae Eukaryota Seeds n.a. n.a. PMID[24597776]
NPO5645 Silybum marianum Species Asteraceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO5645 Silybum marianum Species Asteraceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO5645 Silybum marianum Species Asteraceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO5645 Silybum marianum Species Asteraceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO21361 Anastatica hierochuntica Species Brassicaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO5645 Silybum marianum Species Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT43 Individual Protein Tyrosinase Agaricus bisporus KA = 3.548 10'6L/mol PMID[520985]
NPT43 Individual Protein Tyrosinase Agaricus bisporus KSV = 0.1924 10'4L/mol PMID[520985]
NPT43 Individual Protein Tyrosinase Agaricus bisporus Kis = 37.3 uM PMID[520985]
NPT43 Individual Protein Tyrosinase Agaricus bisporus Ki = 15200.0 nM PMID[520985]
NPT43 Individual Protein Tyrosinase Agaricus bisporus Ki = 15400.0 nM PMID[520985]
NPT43 Individual Protein Tyrosinase Agaricus bisporus IC50 = 28800.0 nM PMID[520985]
NPT43 Individual Protein Tyrosinase Agaricus bisporus Ki = 2100.0 nM PMID[520985]
NPT43 Individual Protein Tyrosinase Agaricus bisporus IC50 = 3200.0 nM PMID[520985]
NPT43 Individual Protein Tyrosinase Agaricus bisporus Kis = 2.9 uM PMID[520985]
NPT1568 Individual Protein Trypsin I Bos taurus IC50 = 144400 nM PMID[9406602]
NPT622 Individual Protein Solute carrier organic anion transporter family member 2B1 Homo sapiens IC50 = 3600 nM PMID[23401473]
NPT2 Others Unspecified Inhibition = 4.1 % PMID[520984]
NPT2 Others Unspecified Inhibition = 1.3 % PMID[520984]
NPT2 Others Unspecified Inhibition = 3.8 % PMID[520984]
NPT2 Others Unspecified Inhibition = 17.4 % PMID[520984]
NPT27 Others Unspecified Inhibition < 8.8 % PMID[520984]
NPT2 Others Unspecified IC50 > 50000.0 nM PMID[520986]
NPT2 Others Unspecified IC50 = 144400 nM PMID[7673925]
NPT2 Others Unspecified IC50 > 130000 nM PMID[23673225]
NPT73 Individual Protein Solute carrier organic anion transporter family member 1B1 Homo sapiens IC50 = 9000 nM PMID[23401473]
NPT72 Individual Protein Solute carrier organic anion transporter family member 1B3 Homo sapiens IC50 = 36400 nM PMID[23401473]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC279209 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC102277
0.956 High Similarity NPC471499
0.956 High Similarity NPC142252
0.9503 High Similarity NPC58223
0.9503 High Similarity NPC36916
0.9503 High Similarity NPC72787
0.9503 High Similarity NPC7688
0.9503 High Similarity NPC125039
0.9503 High Similarity NPC7154
0.9503 High Similarity NPC36
0.95 High Similarity NPC476247
0.95 High Similarity NPC472635
0.9497 High Similarity NPC282009
0.9497 High Similarity NPC470326
0.9497 High Similarity NPC287328
0.9451 High Similarity NPC472454
0.9451 High Similarity NPC257667
0.9451 High Similarity NPC186847
0.9444 High Similarity NPC471213
0.9441 High Similarity NPC472625
0.9437 High Similarity NPC26326
0.9437 High Similarity NPC158188
0.9437 High Similarity NPC289771
0.9434 High Similarity NPC22192
0.9401 High Similarity NPC244903
0.9387 High Similarity NPC260266
0.9387 High Similarity NPC150131
0.9383 High Similarity NPC62261
0.9375 High Similarity NPC472624
0.9371 High Similarity NPC474055
0.9371 High Similarity NPC472598
0.9333 High Similarity NPC121333
0.9329 High Similarity NPC475212
0.9329 High Similarity NPC165456
0.9329 High Similarity NPC107627
0.9321 High Similarity NPC124038
0.9317 High Similarity NPC474038
0.9317 High Similarity NPC66618
0.9317 High Similarity NPC472634
0.9317 High Similarity NPC113163
0.9317 High Similarity NPC165970
0.9317 High Similarity NPC84324
0.9317 High Similarity NPC288131
0.9317 High Similarity NPC472632
0.9317 High Similarity NPC305987
0.9313 High Similarity NPC284127
0.9313 High Similarity NPC53545
0.9313 High Similarity NPC172202
0.9313 High Similarity NPC476410
0.9313 High Similarity NPC117418
0.9308 High Similarity NPC320825
0.9308 High Similarity NPC195796
0.9308 High Similarity NPC278778
0.9308 High Similarity NPC35038
0.9308 High Similarity NPC250922
0.9308 High Similarity NPC13858
0.9308 High Similarity NPC326037
0.9308 High Similarity NPC291878
0.9268 High Similarity NPC295082
0.9264 High Similarity NPC472277
0.9264 High Similarity NPC475888
0.9259 High Similarity NPC474150
0.9259 High Similarity NPC474034
0.9259 High Similarity NPC474162
0.9259 High Similarity NPC211107
0.9259 High Similarity NPC474033
0.9255 High Similarity NPC475784
0.9255 High Similarity NPC192686
0.9255 High Similarity NPC472631
0.9255 High Similarity NPC472962
0.9255 High Similarity NPC36217
0.9255 High Similarity NPC118256
0.9255 High Similarity NPC472630
0.9255 High Similarity NPC470183
0.9255 High Similarity NPC174953
0.9255 High Similarity NPC472961
0.9255 High Similarity NPC101731
0.9255 High Similarity NPC119209
0.925 High Similarity NPC471479
0.925 High Similarity NPC52530
0.925 High Similarity NPC27337
0.925 High Similarity NPC291508
0.925 High Similarity NPC63454
0.925 High Similarity NPC471515
0.925 High Similarity NPC183851
0.9245 High Similarity NPC321779
0.9245 High Similarity NPC477503
0.9245 High Similarity NPC45849
0.9245 High Similarity NPC200761
0.9245 High Similarity NPC470327
0.9217 High Similarity NPC4200
0.9212 High Similarity NPC152477
0.9212 High Similarity NPC242395
0.9212 High Similarity NPC188079
0.9212 High Similarity NPC288813
0.9207 High Similarity NPC320741
0.9207 High Similarity NPC235610
0.9207 High Similarity NPC171985
0.9207 High Similarity NPC224851
0.9207 High Similarity NPC128293
0.9207 High Similarity NPC119589
0.9207 High Similarity NPC43065
0.9202 High Similarity NPC18100
0.9202 High Similarity NPC474240
0.9202 High Similarity NPC186686
0.9202 High Similarity NPC205265
0.9202 High Similarity NPC472281
0.9202 High Similarity NPC476295
0.9202 High Similarity NPC41301
0.9202 High Similarity NPC273959
0.9198 High Similarity NPC187354
0.9198 High Similarity NPC471211
0.9198 High Similarity NPC173137
0.9198 High Similarity NPC471212
0.9198 High Similarity NPC471210
0.9198 High Similarity NPC266314
0.9193 High Similarity NPC473990
0.9187 High Similarity NPC472626
0.9187 High Similarity NPC78492
0.9187 High Similarity NPC209614
0.9187 High Similarity NPC471500
0.9187 High Similarity NPC470328
0.9187 High Similarity NPC208152
0.9182 High Similarity NPC244250
0.9182 High Similarity NPC20907
0.9182 High Similarity NPC18727
0.9182 High Similarity NPC192083
0.9182 High Similarity NPC213896
0.9157 High Similarity NPC131866
0.9152 High Similarity NPC470456
0.9152 High Similarity NPC243877
0.9152 High Similarity NPC474024
0.9152 High Similarity NPC14662
0.9146 High Similarity NPC470457
0.9146 High Similarity NPC326520
0.9146 High Similarity NPC471788
0.9146 High Similarity NPC477840
0.9146 High Similarity NPC300053
0.9146 High Similarity NPC293319
0.9146 High Similarity NPC108433
0.9146 High Similarity NPC224280
0.9141 High Similarity NPC201800
0.9141 High Similarity NPC477841
0.9141 High Similarity NPC219927
0.9136 High Similarity NPC321399
0.9136 High Similarity NPC328102
0.9136 High Similarity NPC476283
0.9136 High Similarity NPC263449
0.913 High Similarity NPC129684
0.913 High Similarity NPC473272
0.913 High Similarity NPC223787
0.913 High Similarity NPC471209
0.913 High Similarity NPC67876
0.913 High Similarity NPC299520
0.913 High Similarity NPC284820
0.9125 High Similarity NPC304745
0.9125 High Similarity NPC226025
0.9125 High Similarity NPC111341
0.9119 High Similarity NPC216035
0.9119 High Similarity NPC260979
0.9119 High Similarity NPC219582
0.9119 High Similarity NPC61506
0.9119 High Similarity NPC236637
0.9119 High Similarity NPC217149
0.9119 High Similarity NPC302950
0.9119 High Similarity NPC260491
0.9119 High Similarity NPC9743
0.9119 High Similarity NPC246162
0.9119 High Similarity NPC106976
0.9119 High Similarity NPC472912
0.9119 High Similarity NPC36835
0.9119 High Similarity NPC240476
0.9119 High Similarity NPC19721
0.9107 High Similarity NPC108202
0.9096 High Similarity NPC300307
0.9096 High Similarity NPC177480
0.9096 High Similarity NPC326877
0.9091 High Similarity NPC173292
0.9091 High Similarity NPC13481
0.9091 High Similarity NPC207575
0.9091 High Similarity NPC43319
0.9091 High Similarity NPC477517
0.9091 High Similarity NPC470462
0.9091 High Similarity NPC170245
0.9085 High Similarity NPC470459
0.9085 High Similarity NPC472582
0.9085 High Similarity NPC63438
0.908 High Similarity NPC301256
0.908 High Similarity NPC112418
0.908 High Similarity NPC134783
0.908 High Similarity NPC312273
0.908 High Similarity NPC308992
0.908 High Similarity NPC474239
0.9074 High Similarity NPC123544
0.9074 High Similarity NPC55738
0.9074 High Similarity NPC250214
0.9074 High Similarity NPC210459
0.9074 High Similarity NPC95936
0.9068 High Similarity NPC20530
0.9068 High Similarity NPC215917

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC279209 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9503 High Similarity NPD6168 Clinical (unspecified phase)
0.9503 High Similarity NPD6167 Clinical (unspecified phase)
0.9503 High Similarity NPD6166 Phase 2
0.9182 High Similarity NPD2393 Clinical (unspecified phase)
0.9119 High Similarity NPD1934 Approved
0.8951 High Similarity NPD3882 Suspended
0.8902 High Similarity NPD5494 Approved
0.8817 High Similarity NPD7074 Phase 3
0.881 High Similarity NPD3818 Discontinued
0.8773 High Similarity NPD8443 Clinical (unspecified phase)
0.8765 High Similarity NPD6797 Phase 2
0.8758 High Similarity NPD4380 Phase 2
0.8757 High Similarity NPD7054 Approved
0.872 High Similarity NPD4868 Clinical (unspecified phase)
0.8713 High Similarity NPD7251 Discontinued
0.8712 High Similarity NPD2801 Approved
0.8706 High Similarity NPD7472 Approved
0.8667 High Similarity NPD7075 Discontinued
0.8663 High Similarity NPD7808 Phase 3
0.8663 High Similarity NPD4338 Clinical (unspecified phase)
0.8659 High Similarity NPD3817 Phase 2
0.8625 High Similarity NPD1512 Approved
0.8562 High Similarity NPD4378 Clinical (unspecified phase)
0.8547 High Similarity NPD7993 Clinical (unspecified phase)
0.8538 High Similarity NPD5844 Phase 1
0.8538 High Similarity NPD7804 Clinical (unspecified phase)
0.8529 High Similarity NPD7473 Discontinued
0.8512 High Similarity NPD6959 Discontinued
0.85 High Similarity NPD1511 Approved
0.8485 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8462 Intermediate Similarity NPD6232 Discontinued
0.8443 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8424 Intermediate Similarity NPD6801 Discontinued
0.8391 Intermediate Similarity NPD6559 Discontinued
0.8364 Intermediate Similarity NPD7411 Suspended
0.8333 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8263 Intermediate Similarity NPD7819 Suspended
0.8239 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8239 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8198 Intermediate Similarity NPD3926 Phase 2
0.8187 Intermediate Similarity NPD1549 Phase 2
0.815 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8107 Intermediate Similarity NPD5402 Approved
0.8101 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.8092 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.8081 Intermediate Similarity NPD7199 Phase 2
0.8081 Intermediate Similarity NPD1247 Approved
0.807 Intermediate Similarity NPD919 Approved
0.8049 Intermediate Similarity NPD6799 Approved
0.8047 Intermediate Similarity NPD1465 Phase 2
0.8012 Intermediate Similarity NPD5403 Approved
0.7976 Intermediate Similarity NPD6599 Discontinued
0.7965 Intermediate Similarity NPD6234 Discontinued
0.7955 Intermediate Similarity NPD7228 Approved
0.7953 Intermediate Similarity NPD7768 Phase 2
0.795 Intermediate Similarity NPD2796 Approved
0.7907 Intermediate Similarity NPD3749 Approved
0.7904 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7892 Intermediate Similarity NPD5401 Approved
0.7888 Intermediate Similarity NPD1510 Phase 2
0.7882 Intermediate Similarity NPD37 Approved
0.788 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7869 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7862 Intermediate Similarity NPD1613 Approved
0.7862 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7849 Intermediate Similarity NPD4966 Approved
0.7849 Intermediate Similarity NPD4965 Approved
0.7849 Intermediate Similarity NPD4967 Phase 2
0.7805 Intermediate Similarity NPD2800 Approved
0.779 Intermediate Similarity NPD8313 Approved
0.779 Intermediate Similarity NPD8312 Approved
0.7784 Intermediate Similarity NPD2532 Approved
0.7784 Intermediate Similarity NPD2534 Approved
0.7784 Intermediate Similarity NPD2533 Approved
0.7753 Intermediate Similarity NPD3751 Discontinued
0.775 Intermediate Similarity NPD1240 Approved
0.7736 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7735 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7727 Intermediate Similarity NPD3787 Discontinued
0.7713 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7697 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7679 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7673 Intermediate Similarity NPD3027 Phase 3
0.7663 Intermediate Similarity NPD8434 Phase 2
0.7663 Intermediate Similarity NPD8150 Discontinued
0.7654 Intermediate Similarity NPD1607 Approved
0.764 Intermediate Similarity NPD943 Approved
0.7636 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7619 Intermediate Similarity NPD7390 Discontinued
0.7619 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.761 Intermediate Similarity NPD4908 Phase 1
0.761 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7605 Intermediate Similarity NPD6190 Approved
0.7592 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7592 Intermediate Similarity NPD6781 Approved
0.7592 Intermediate Similarity NPD6776 Approved
0.7592 Intermediate Similarity NPD6777 Approved
0.7592 Intermediate Similarity NPD6778 Approved
0.7592 Intermediate Similarity NPD6779 Approved
0.7592 Intermediate Similarity NPD6780 Approved
0.7592 Intermediate Similarity NPD6782 Approved
0.7582 Intermediate Similarity NPD7685 Pre-registration
0.7574 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7547 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7545 Intermediate Similarity NPD4628 Phase 3
0.7545 Intermediate Similarity NPD3750 Approved
0.7515 Intermediate Similarity NPD2935 Discontinued
0.7513 Intermediate Similarity NPD4363 Phase 3
0.7513 Intermediate Similarity NPD4360 Phase 2
0.75 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD3226 Approved
0.7486 Intermediate Similarity NPD7240 Approved
0.7485 Intermediate Similarity NPD920 Approved
0.7474 Intermediate Similarity NPD7435 Discontinued
0.747 Intermediate Similarity NPD2344 Approved
0.7462 Intermediate Similarity NPD8151 Discontinued
0.7455 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7442 Intermediate Similarity NPD1653 Approved
0.7439 Intermediate Similarity NPD6651 Approved
0.7436 Intermediate Similarity NPD7871 Phase 2
0.7436 Intermediate Similarity NPD7870 Phase 2
0.743 Intermediate Similarity NPD7229 Phase 3
0.7429 Intermediate Similarity NPD8455 Phase 2
0.741 Intermediate Similarity NPD6099 Approved
0.741 Intermediate Similarity NPD6100 Approved
0.7385 Intermediate Similarity NPD7698 Approved
0.7385 Intermediate Similarity NPD7696 Phase 3
0.7385 Intermediate Similarity NPD7697 Approved
0.7381 Intermediate Similarity NPD1243 Approved
0.7378 Intermediate Similarity NPD230 Phase 1
0.7374 Intermediate Similarity NPD8127 Discontinued
0.7368 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7353 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7349 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7349 Intermediate Similarity NPD2799 Discontinued
0.7337 Intermediate Similarity NPD5953 Discontinued
0.7333 Intermediate Similarity NPD5710 Approved
0.7333 Intermediate Similarity NPD5711 Approved
0.733 Intermediate Similarity NPD6534 Approved
0.733 Intermediate Similarity NPD6535 Approved
0.7323 Intermediate Similarity NPD7701 Phase 2
0.7305 Intermediate Similarity NPD1551 Phase 2
0.7301 Intermediate Similarity NPD6798 Discontinued
0.7301 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.73 Intermediate Similarity NPD7801 Approved
0.73 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.73 Intermediate Similarity NPD7783 Phase 2
0.7294 Intermediate Similarity NPD2309 Approved
0.7292 Intermediate Similarity NPD4361 Phase 2
0.7292 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7282 Intermediate Similarity NPD2494 Approved
0.7282 Intermediate Similarity NPD2493 Approved
0.7273 Intermediate Similarity NPD6355 Discontinued
0.7273 Intermediate Similarity NPD7584 Approved
0.7273 Intermediate Similarity NPD447 Suspended
0.7263 Intermediate Similarity NPD2490 Approved
0.7263 Intermediate Similarity NPD2488 Approved
0.7262 Intermediate Similarity NPD2346 Discontinued
0.7259 Intermediate Similarity NPD4582 Approved
0.7259 Intermediate Similarity NPD4583 Approved
0.7253 Intermediate Similarity NPD2403 Approved
0.725 Intermediate Similarity NPD7874 Approved
0.725 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7246 Intermediate Similarity NPD3748 Approved
0.7235 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7228 Intermediate Similarity NPD7286 Phase 2
0.722 Intermediate Similarity NPD4111 Phase 1
0.722 Intermediate Similarity NPD4665 Approved
0.7216 Intermediate Similarity NPD7700 Phase 2
0.7216 Intermediate Similarity NPD7699 Phase 2
0.7212 Intermediate Similarity NPD4060 Phase 1
0.7208 Intermediate Similarity NPD4004 Approved
0.7208 Intermediate Similarity NPD7680 Approved
0.7208 Intermediate Similarity NPD4002 Approved
0.72 Intermediate Similarity NPD7458 Discontinued
0.7194 Intermediate Similarity NPD3450 Approved
0.7194 Intermediate Similarity NPD3452 Approved
0.7179 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7176 Intermediate Similarity NPD6674 Discontinued
0.7172 Intermediate Similarity NPD8320 Phase 1
0.7172 Intermediate Similarity NPD8319 Approved
0.717 Intermediate Similarity NPD1610 Phase 2
0.7169 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7169 Intermediate Similarity NPD1933 Approved
0.7169 Intermediate Similarity NPD5124 Phase 1
0.7157 Intermediate Similarity NPD6823 Phase 2
0.7152 Intermediate Similarity NPD6233 Phase 2
0.715 Intermediate Similarity NPD7907 Approved
0.7143 Intermediate Similarity NPD7033 Discontinued
0.7135 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7135 Intermediate Similarity NPD5761 Phase 2
0.7135 Intermediate Similarity NPD5760 Phase 2
0.7126 Intermediate Similarity NPD6273 Approved
0.7119 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7118 Intermediate Similarity NPD2424 Discontinued
0.7117 Intermediate Similarity NPD9494 Approved
0.7117 Intermediate Similarity NPD2861 Phase 2
0.7091 Intermediate Similarity NPD2313 Discontinued
0.7081 Intermediate Similarity NPD2163 Approved
0.7081 Intermediate Similarity NPD4379 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data